Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenon Medical (TNON) Change in Accured Expenses (2021 - 2025)

Historic Change in Accured Expenses for Tenon Medical (TNON) over the last 5 years, with Q3 2025 value amounting to $499000.0.

  • Tenon Medical's Change in Accured Expenses rose 30619.83% to $499000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $327000.0, marking a year-over-year increase of 16160.0%. This contributed to the annual value of -$171000.0 for FY2024, which is 7272.73% down from last year.
  • As of Q3 2025, Tenon Medical's Change in Accured Expenses stood at $499000.0, which was up 30619.83% from $55000.0 recorded in Q2 2025.
  • In the past 5 years, Tenon Medical's Change in Accured Expenses registered a high of $2.8 million during Q4 2022, and its lowest value of -$1.1 million during Q3 2022.
  • Over the past 5 years, Tenon Medical's median Change in Accured Expenses value was $20000.0 (recorded in 2021), while the average stood at $162368.4.
  • Data for Tenon Medical's Change in Accured Expenses shows a peak YoY increase of 660000.0% (in 2024) and a maximum YoY decrease of 164444.44% (in 2024) over the last 5 years.
  • Quarter analysis of 5 years shows Tenon Medical's Change in Accured Expenses stood at $258000.0 in 2021, then surged by 974.81% to $2.8 million in 2022, then plummeted by 100.65% to -$18000.0 in 2023, then tumbled by 1644.44% to -$314000.0 in 2024, then surged by 258.92% to $499000.0 in 2025.
  • Its Change in Accured Expenses stands at $499000.0 for Q3 2025, versus $55000.0 for Q2 2025 and $87000.0 for Q1 2025.